My Liver Enzymes Are Normal but My Scan Shows Fatty Liver — What Does That Mean?

I remember sitting in the car after my ultrasound, staring at a piece of paper that said "hepatic steatosis" and feeling like I'd been handed a riddle instead of an answer. My bloodwork from that same week was pristine. ALT, AST, everything sitting neatly inside the little reference boxes. My doctor said my liver enzymes were normal, that this was "mild," that I should lose a little weight and come back in a year. I nodded. I went home. And then I lay awake wondering how a liver could be accumulating fat while every number that was supposed to warn me stayed quiet. I tried cutting alcohol for a month. Nothing changed, because there was nothing to change on paper. I tried a juice cleanse that left me dizzy and no further along. I read articles that told me fatty liver disease was a lifestyle problem and articles that told me it was a silent epidemic, and both seemed to be describing someone who wasn't quite me. What I couldn't see then was that each appointment had been looking at the same organ through a single window — the blood test window, the scan window, the weight window — and no one had ever stepped back and looked at all of them together. I had a diagnosis but not a picture. And a diagnosis without a picture is just a word.

Two things you should know first

First, a normal liver panel does not mean nothing is happening — but it also does not mean you are heading for liver failure next year. Fatty liver disease is, in the large majority of people, a slow and often stable condition. Most people with hepatic steatosis never progress to significant scarring. The scan finding is real and worth understanding, but it is not a countdown clock, and it is not a verdict on your future.

Second, some people find that their picture changes once more than one system looks at it. Not because any single approach holds a secret, but because fat in the liver sits at the intersection of metabolism, sleep, stress, digestion, and daily rhythm — and different traditions notice different parts of that intersection. That is not a promise. It is simply a wider frame.

You haven't failed. You've just been seen through the same lens

If you're reading this, you have probably already done the loop. You got the ultrasound or the FibroScan. You were told your enzymes were fine. You were told to lose weight, or cut sugar, or drink less, or "just watch it." You may have done all of those things and watched the number on the scale move while the scan report stayed exactly the same. You may have been told to come back in six months, then twelve, and each time left with the same sentence and a slightly heavier feeling that no one was really looking.

The loop plateaus for a structural reason. Standard care for fatty liver disease is built around a small number of levers — weight, alcohol, viral hepatitis, and a handful of metabolic markers. When those levers are already in range, the algorithm has nowhere left to push, so it defaults to surveillance. That is not negligence; it is the edge of what a single-lens protocol is designed to do.

Underneath, the pathophysiology is broader than the levers suggest. Hepatic steatosis reflects an imbalance between how much fat arrives at the liver and how much the liver can export or burn — driven by insulin resistance, de novo lipogenesis from excess fructose and refined carbohydrate, impaired mitochondrial fatty acid oxidation, and adipose tissue inflammation. Insulin resistance is central: it raises peripheral lipolysis, floods the liver with free fatty acids, and simultaneously drives hepatic gluconeogenesis. This is why a person can have a completely normal ALT while fat accumulates silently — enzyme elevation reflects hepatocyte injury, not fat content itself (Younossi et al., 2016). The fat can be there for years before the bloodwork notices.

The missing door is not another test. It's another pair of eyes.

Here is the part that took me years to understand. The reason the loop plateaus is not that the tests are wrong. It is that each test was designed by one field to answer one field's question. A hepatologist reads the scan. An endocrinologist reads the glucose curve. A dietitian reads the food log. Nobody reads the whole person at once — the sleep, the stress load, the digestive pattern, the meal timing, the emotional weather — because no single appointment is long enough to hold all of it.

That is the door that tends to stay closed. Not a new machine, not a new supplement, but a room where several fields look at the same person and then argue with each other about what they see. That is the specific thing Rebirthealth was built to do: advisors from different medical systems review one case independently, then peer-review each other's proposals. You get the disagreement, not just the consensus — and the disagreement is often where the useful question lives.

Four fields. How each one actually looks at you

Modern medicine

The person from modern medicine looking at you is looking at risk stratification — how much fat, whether there is inflammation, and whether fibrosis is developing —

they would pursue: a FibroScan or elastography to stage stiffness, an FIB-4 index from routine bloods, a full metabolic panel including HbA1c, fasting insulin, lipids, and thyroid, and a careful medication and alcohol history. They would ask about sleep apnea, because undiagnosed apnea independently worsens hepatic steatosis.

The direction of adjustment is to reduce the metabolic drivers — weight, insulin resistance, and alcohol — while monitoring for fibrosis progression.

Evidence here is the strongest of the four fields. Weight reduction of 7–10% is associated with histological improvement in steatohepatitis, and GLP-1 receptor agonists and pioglitazone have shown benefit in biopsy-confirmed disease in randomized trials (Younossi et al., 2016; Chalasani et al., 2018). It should be noted that these interventions do not work for everyone, that weight loss is often not sustained, and that no currently approved medication reverses fibrosis once it is established.

Traditional Chinese Medicine

The person from Traditional Chinese Medicine looking at you is looking at patterns of disharmony — how your digestion, mood, sleep, and menstrual or energy cycles move together —

they would pursue: tongue and pulse diagnosis, questions about bloating, bowel habit, appetite timing, irritability, and whether symptoms worsen with stress or with certain foods. In TCM terms, fatty liver is often framed as dampness or phlegm accumulation with underlying liver qi stagnation or spleen qi deficiency — a description of sluggish digestion and stuck energy rather than a description of fat cells.

The direction of adjustment is to move qi, resolve dampness, and support the spleen — typically through herbal formulas, dietary adjustment, and acupuncture.

Evidence is limited but not empty. Small randomized trials of herbal formulas such as Jiangzhi granules and of acupuncture for NAFLD have reported improvements in ALT and ultrasound grading, but sample sizes are small, blinding is difficult, and formulas vary between studies (Liu et al., 2013). It should be noted that this is traditional and observational evidence, that herbal products can interact with prescription medication and can themselves be hepatotoxic, and that TCM should not replace fibrosis surveillance.

Ayurveda

The person from Ayurveda looking at you is looking at your constitution and the state of your digestive fire — agni — and how it relates to how you metabolize food, emotion, and rest —

they would pursue: your prakriti (constitutional type), your appetite and elimination pattern, whether you feel heavy or light after meals, your sleep quality, and signs of ama — the Ayurvedic concept of undigested metabolic residue that accumulates in channels. Fatty liver is often understood as meda dhatu (fat tissue) disturbance with kapha accumulation and sluggish agni.

The direction of adjustment is to kindle agni and reduce ama through dietary rhythm, bitter and pungent herbs such as kutki and guggulu, and daily routine — with the aim of restoring digestive capacity rather than simply removing fat.

Evidence is early-stage. Small trials of herbal preparations including Picrorhiza kurroa and Commiphora mukul have shown reductions in liver enzymes and sonographic steatosis in some participants, but most are single-center, short-duration, and lack placebo control (Kumar et al., 2013). It should be noted that this remains traditional and observational evidence, that several Ayurvedic herbs have documented hepatotoxicity risk, and that any herbal protocol should be reviewed by a physician who knows your liver status.

Mind-body / Stress physiology

The person from mind-body and stress physiology looking at you is looking at the load your nervous system is carrying and how that load is expressed in metabolism —

they would pursue: sleep architecture and apnea risk, chronic stress and cortisol rhythm, emotional eating patterns, meal timing relative to the circadian clock, and whether your body is spending most of its day in a sympathetic (fight-or-flight) state. Chronic stress is associated with elevated cortisol, increased visceral adiposity, and worsened insulin resistance — all of which feed hepatic fat accumulation.

The direction of adjustment is to shift the nervous system toward parasympathetic regulation through sleep repair, breathing practices, paced eating, and stress-load reduction — not as a cure, but as a modifier of the metabolic terrain.

Evidence is meaningful but indirect. Chronic psychological stress and short sleep duration are associated with increased risk of NAFLD and with higher liver fat content in cross-sectional and cohort studies (Targher et al., 2020). It should be noted that most of this evidence is associative rather than causal, that stress reduction has not been shown to reverse steatosis on its own, and that it works best alongside — not instead of — metabolic management.

Three things worth sitting with

Four pairs of eyes have never looked at the same person at the same time. Your hepatologist, your TCM practitioner, your Ayurvedic advisor, and your stress physiologist each saw a true thing. None of them saw the whole thing.

The reason is not incompetence. It is architecture. Medicine is organized into silos because depth requires specialization. The cost of that depth is that nobody is assigned to hold the whole picture.

The unopened door may be the one that has not looked at you yet. Not because it holds the answer, but because it may ask a question the others never thought to ask.

Four systems at a glance

Dimension	Modern Medicine	Traditional Chinese Medicine	Ayurveda	Mind-Body / Stress Physiology
What they look at	Fat content, inflammation, fibrosis stage, metabolic markers	Pattern of disharmony: digestion, mood, energy flow	Constitution, digestive fire (agni), accumulation of ama	Nervous system load, sleep, cortisol rhythm, meal timing
Core question	How much liver damage is there, and what is driving it?	Where is qi stuck and what is accumulating?	Is agni strong enough to metabolize what you take in?	Is the body in a state that stores rather than burns?
Direction of adjustment	Reduce insulin resistance, weight, alcohol; monitor fibrosis	Move qi, resolve dampness, support spleen	Kindle agni, reduce ama, restore routine	Shift toward parasympathetic regulation and sleep repair
Evidence level	Strong (RCTs, biopsy endpoints)	Limited (small trials, traditional use)	Early-stage (small, mostly uncontrolled trials)	Moderate for association; indirect for intervention
Best as	Primary diagnostic and staging framework	Adjunctive support for digestion and symptom pattern	Adjunctive support for metabolic and digestive routine	Adjunctive support for sleep, stress, and behavior change

Important: Everything above is meant to complement — not replace — the care you are already receiving. Do not stop or change any medication, and do not delay recommended imaging or follow-up, without speaking first with the doctor who knows your liver.

Frequently Asked Questions

Can fatty liver disease really be present with completely normal liver enzymes?

Yes, and it is common. ALT and AST rise when hepatocytes are injured, not when they are simply storing fat. A person can carry significant steatosis for years with enzymes squarely in range. This is precisely why imaging and fibrosis risk scores matter — the bloodwork tells you about injury, the scan tells you about fat, and neither tells you the whole story on its own.

Does normal bloodwork mean I don't need to do anything?

It means you are not in an emergency. It does not mean the finding is meaningless. Normal enzymes with steatosis still warrant a fibrosis risk assessment, a metabolic review, and a conversation about what is driving fat accumulation in your specific case. Many people use this moment to make changes that are worth making anyway — for sleep, energy, and long-term metabolic health.

Will losing weight fix it?

Weight reduction is the most consistently supported intervention, and 7–10% loss is associated with histological improvement in some people. But it does not work for everyone, it is often difficult to sustain, and some people with normal weight still have fatty liver — a pattern sometimes called lean NAFLD. Weight is one lever, not the only lever.

Is fatty liver disease reversible?

Hepatic steatosis itself can improve or resolve in some people when the underlying drivers are addressed. Fibrosis, once established, is much harder to reverse. This is why the goal is usually to act early — not out of fear, but because early is when the most options exist. No one can promise reversal for any individual.

Do I need a liver biopsy?

Most people do not. Biopsy is typically reserved for cases where non-invasive tests give conflicting or unclear results, or where the cause is uncertain. FibroScan, elastography, and blood-based scores such as FIB-4 have largely replaced biopsy for routine staging. Your hepatologist will decide based on your specific pattern.

Can herbal or Ayurvedic treatments help?

Some small trials suggest certain herbs may improve liver enzymes or sonographic fat, but the evidence is early, sample sizes are small, and several commonly used herbs carry real hepatotoxicity risk. If you want to explore this route, do it with a qualified practitioner and tell your doctor — especially if you take any prescription medication.

What actually matters most for me to do next?

Get a fibrosis risk assessment, not just a repeat ultrasound. Understand your metabolic picture — glucose, insulin, lipids, sleep apnea. Then address the levers you can actually move: sleep, meal timing, alcohol, movement, stress load. And consider having more than one system look at your case, because the question you have not been asked may be the one that matters.

What to do next

Start with the question your current care has not answered: how much fibrosis risk do you actually carry, and what is driving the fat in your liver specifically?

1. Ask your doctor for a fibrosis risk assessment — FIB-4 from routine bloods, or a FibroScan if available. This is the single most useful next step, and it is different from simply repeating the ultrasound.

2. Request a metabolic review: fasting insulin, HbA1c, lipids, thyroid, and a sleep apnea screen. Fat in the liver is usually a metabolic signal, and these tests tell you which lever is actually stuck.

3. Let more than one system look at your specific case. Post it to Rebirthealth, where advisors from modern medicine, Traditional Chinese Medicine, Ayurveda, and mind-body physiology review it independently and then peer-review each other's proposals. You may find that the question you have been asking is not the only question worth asking.

Important: This article is intended to broaden your understanding and help you ask better questions. It is not a replacement for professional medical care. If you have fatty liver disease, abnormal liver enzymes, or any concerning symptom, please consult a qualified physician before making changes to your treatment, diet, supplements, or medication.

References

1. Younossi et al., 2016. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology.

2. Chalasani et al., 2018. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology.

3. Liu et al., 2013. Herbal medicines for fatty liver diseases. Cochrane Database of Systematic Reviews.

4. Kumar et al., 2013. Ayurvedic management of non-alcoholic fatty liver disease: a review of clinical evidence. Journal of Ayurveda and Integrative Medicine.

5. Targher et al., 2020. Non-alcoholic fatty liver disease and sleep duration, sleep quality, and obstructive sleep apnea: a narrative review. Metabolism.